Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Nat Clin Pract Oncol. 2005 Aug;2(8):416-22.

PMID:
16130938
2.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Nat Clin Pract Urol. 2005 Aug;2(8):416-22.

PMID:
16482653
3.

Reporting recommendations for tumor marker prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

J Natl Cancer Inst. 2005 Aug 17;97(16):1180-4.

PMID:
16106022
4.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics.

Breast Cancer Res Treat. 2006 Nov;100(2):229-35. Epub 2006 Aug 24.

PMID:
16932852
5.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Eur J Cancer. 2005 Aug;41(12):1690-6.

PMID:
16043346
6.

Reporting recommendations for tumor marker prognostic studies (remark).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Exp Oncol. 2006 Jun;28(2):99-105.

PMID:
16837898
7.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Br J Cancer. 2005 Aug 22;93(4):387-91.

8.

Reporting recommendations for tumor marker prognostic studies.

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

J Clin Oncol. 2005 Dec 20;23(36):9067-72. Epub 2005 Sep 19. No abstract available.

PMID:
16172462
9.

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK.

Hayes DF, Ethier S, Lippman ME.

Breast Cancer Res Treat. 2006 Nov;100(2):237-8. Epub 2006 Jun 14. No abstract available.

PMID:
16773436
10.

Re: Reporting recommendations for tumor marker prognostic studies (REMARK).

Popat S, Houlston RS.

J Natl Cancer Inst. 2005 Dec 21;97(24):1855; author reply 1855-6. No abstract available.

PMID:
16368950
11.

How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.

Ransohoff DF.

J Clin Epidemiol. 2007 Dec;60(12):1205-19. Epub 2007 Sep 24. Review.

PMID:
17998073
12.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
13.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. German.

PMID:
19034813
14.

Practice guidelines for tumor marker use in the clinic.

Sturgeon C.

Clin Chem. 2002 Aug;48(8):1151-9. Review.

15.

The International Bladder Cancer Bank: proposal for a new study concept.

Goebell PJ, Groshen S, Schmitz-Dräger BJ, Sylvester R, Kogevinas M, Malats N, Sauter G, Barton Grossman H, Waldman F, Cote RJ.

Urol Oncol. 2004 Jul-Aug;22(4):277-84.

PMID:
15283883
16.

Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect.

Kyzas PA, Denaxa-Kyza D, Ioannidis JP.

J Natl Cancer Inst. 2007 Feb 7;99(3):236-43.

PMID:
17284718
17.

Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.

Freeman K, Szczepura A, Osipenko L.

Eur J Obstet Gynecol Reprod Biol. 2009 Feb;142(2):91-8. doi: 10.1016/j.ejogrb.2008.10.010. Epub 2008 Dec 9. Review.

PMID:
19081172
18.
19.

Quality of reporting of test accuracy studies in reproductive medicine: impact of the Standards for Reporting of Diagnostic Accuracy (STARD) initiative.

Coppus SF, van der Veen F, Bossuyt PM, Mol BW.

Fertil Steril. 2006 Nov;86(5):1321-9. Epub 2006 Sep 14.

PMID:
16978620
20.

Supplemental Content

Support Center